FDA Inspection 1232268 — OsteoMed, LLC
The FDA completed an inspection of OsteoMed, LLC on Aug 16, 2024 in Addison, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 16, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Addison, TX (United States)